Genomic variants associated with cancer-related fatigue: A systematic review

Clinical Journal of Oncology Nursing

Volumn 20, Issue 5, 2016, Pages 537-546

  Tariman, Joseph D ^a   Dhorajiwala, Sadaf ^a  

^a DEPAUL UNIVERSITY   (United States)

Author keywords

Cancer; Fatigue; Gene pathway analysis; Genomic variants; Next generation gene sequencing; Single nucleotide polymorphism

Indexed keywords

ADULT; AGED; COMPLICATION; FATIGUE; FEMALE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOMICS; HUMAN; MALE; MIDDLE AGED; NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FATIGUE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOMICS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS;

EID: 84988905863     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/16.CJON.537-546     Document Type: Review

References (34)

1. Aouizerat, B.E., Dodd, M., Lee, K., West, C., Paul, S.M., Cooper, B.A, Miaskowski, C. (2009). Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biological Research for Nursing, 11, 27-41. Doi:10.1177/1099800409333871
2. Bower, J.E., Ganz, P.A., Irwin, M.R., Arevalo, J.M., & Cole, S.W. (2011). Fatigue and genomic expression in human leukocytes: Increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain, Behavior, and Immunity, 25, 147-150. Doi:10.1016/j.bbi.2010.09.010
3. Bower, J.E., Ganz, P.A., Irwin, M.R., Castellon, S., Arevalo, J., & Cole, S.W. (2013). Cytokine genetic variations and fatigue among patients with breast cancer. Journal of Clinical Oncology, 31, 1656-1661. Doi:10.1200/JCO.2012.46.2143
4. Bower, J.E., & Lamkin, D.M. (2013). Inflammation and cancerrelated fatigue: Mechanisms, contributing factors, and treatment implications. Brain, Behavior, and Immunity, 30(Suppl.), S48-S57. Doi:10.1016/j.bbi.2012.06.011
5. Centers for Disease Control and Prevention. (2015). CFS case definition. Retrieved from http://www.cdc.gov/cfs/case-definition
6. Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D, Wallace, E.P. (1993). Development of a fatigue scale. Journal of Psychosomatic Research, 37, 147-153.
7. Collado-Hidalgo, A., Bower, J.E., Ganz, P.A., Irwin, M.R., & Cole, S.W. (2008). Cytokine genomic polymorphisms and fatigue in breast cancer survivors: Early findings. Brain, Behavior, and Immunity, 22, 1197-1200. Doi:10.1016/j.bbi.2008.05.009
8. Cramp, F., & Daniel, J. (2008). Exercise for the management of cancer‐ related fatigue in adults. Cochrane Database of Systematic Reviews, 11, CD006145. Doi:10.1002/14651858.CD006145.pub3
9. Dhruva, A., Aouizerat, B.E., Cooper, B., Paul, S.M., Dodd, M., West, C, Miaskowski, C (2015). Cytokine genomic associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers. Biological Research for Nursing, 17, 175-184. Doi:10.1177/1099800414534313
10. Fernandez-de-las-Penas, C., Fernandez-Lao, C., Cantarero-Villanueva, I., Ambite-Quesada, S., Rivas-Martinez, I., del Moral-Avila, R, Arroyo-Morales, M. (2012). Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast Cancer Research and Treatment, 133, 405-412. Doi:10.1007/s10549-011-1757-y
11. Filler, K., Lyon, D., Bennett, J., McCain, N., Elswick, R., Lukkahatai, N., & Saligan, L.N. (2014). Association of mitochondrial dysfunction and fatigue: A review of the literature. BBA Clinical, 1, 12-23.
12. Hsiao, C.P., Araneta, M., Wang, X.M., & Saligan, L.N. (2013). The association of IFI27 expression and fatigue intensification during localized radiation therapy: Implication of a parainflammatory bystander response. International Journal of Molecular Sciences, 14, 16943-16957. Doi:10.3390/ijms140816943
13. Hsiao, C.P., Wang, D., Kaushal, A., Chen, M.K., & Saligan, L. (2014). Differential expression of genes related to mitochondrial biogenesis and bioenergetics in fatigued prostate cancer men receiving external beam radiation therapy. Journal of Pain and Symptom Management, 48, 1080-1090. Doi:10.1016/j.jpainsymman.2014.03.010
14. Jim, H.S., Park, J.Y., Permuth-Wey, J., Rincon, M.A., Phillips, K.M., Small, B.J., & Jacobsen, P.B. (2012). Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings. Brain, Behavior, and Immunity, 26, 1030-1036. Doi:10.1016/j.bbi.2012.03.001
15. Johns, S.A., Brown, L.F., Beck-Coon K, Monahan, P.O, Tong, Y & Kroenke, K. (2014). Randomized controlled pilot study of mindfulness‐ based stress reduction for persistently fatigued cancer survivors. Psycho‐Oncology, 24, 885-893. Doi:10.1002/pon.3648
16. Landmark-Hoyvik, H., Reinertsen, K.V., Loge, J.H., Fossa, S.D., Borresen-Dale, A.L., & Dumeaux, V. (2009). Alterations of genomic expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics Journal, 9, 333-340. Doi:10.1038/tpj.2009.27
17. Light, K.C., Agarwal, N., Iacob, E., White, A.T., Kinney, A.Y., VanHaitsma, T.A, Light, A.R. (2013). Differing leukocyte genomic expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome. Psychoneuroendocrinology, 38, 2983-2995. Doi:10.1016/j.psyneuen.2013.08.008
18. Massacesi, C., Terrazzino, S., Marcucci, F., Rocchi, M.B., Lippe, P., Bisonni, R., … Leon, A. (2006). Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy. Cancer, 106, 1007-1016. Doi:10.1002/cncr.21722
19. Miaskowski, C., Dodd, M., Lee, K., West, C., Paul, S.M., Cooper, B.A, Aouizerat, B.E. (2010). Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. Journal of Pain and Symptom Management, 40, 531-544. Doi:10.1016/j.jpainsymman.2009.12.006
20. National Cancer Institute. (2016). Fatigue PDQR. Retrieved from http://bit.ly/2d1C6E5
21. Navalta, J.W., Tibana, R.A., Fedor, E.A., Vieira, A., & Prestes, J. (2014). Three consecutive days of interval runs to exhaustion affects lymphocyte subset apoptosis and migration. Biomed Research International, 2014, 694801. Doi:10.1155/2014/694801
22. News-Medical.Net. (2016, January). What is a biomarker? Retrieved from http://bit.ly/2dghkjg
23. Payne, J.K. (2004). A neuroendocrine-based regulatory fatigue model. Biological Research for Nursing, 6, 141-150.
24. Piper, B.F., & Cella, D. (2010). Cancer-related fatigue: Definitions and clinical subtypes. Journal of the National Comprehensive Cancer Network, 8, 958-966.
25. Piraino, B., Vollmer-Conna, U., & Lloyd, A.R. (2012). Genetic associations of fatigue and other symptom domains of the acute sickness response to infection. Brain, Behavior, and Immunity, 26, 552-558. Doi:10.1016/j.bbi.2011.12.009
26. Rausch, S.M., Clark, M.M., Patten, C., Liu, H., Felten, S., Li, Y, Yang, P. (2010). Relationship between cytokine genomic single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer, 116, 4103-4113.
27. Reyes-Gibby, C.C., Wang, J., Spitz, M., Wu, X., Yennurajalingam, S., & Shete, S. (2013). Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. Journal of Pain and Symptom Management, 46, 161-172. Doi:10.1016/j.jpainsymman.2012.07.019
28. Saligan, L.N., Hsiao, C.P., Wang, D., Wang, X.M., St John, L., Kaushal, A, Dionne R.A. (2013). Upregulation of alphasynuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways. Brain, Behavior, and Immunity, 27, 63-70. Doi:10.1016/j.bbi.2012.09.009
29. Saligan, L.N., & Kim, H.S. (2012). A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain, Behavior, and Immunity, 26, 830-848. Doi:10.1016/j.bbi.2012.05.004
30. Saligan, L.N., Olson, K., Filler, K., Larkin, D., Cramp, F., Yennurajalingam, S, Mustian, K. (2015). The biology of cancerrelated fatigue: A review of the literature. Supportive Care in Cancer, 23, 2461-2478. Doi:10.1007/s00520-015-2763-0
31. Vilchvnska, T., & Beard, B. (2016). Cancer-related fatigue in palliative care: A global perspective. International Journal of Palliative Nursing, 22, 244-252. Doi:10.12968/ijpn.2016.22.5.244
32. Wang, X.S., & Woodruff, J.F. (2015). Cancer-related and treatmentrelated fatigue. Gynecologic Oncology, 136, 446-452.
33. Yellen, S.B., Cella, D.F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Journal of Pain and Symptom Management, 13, 63-74.
34. Yost, K.J., Eton, D.T., Garcia, S.F., & Cella D. (2011). Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. Journal of Clinical Epidemiology, 64, 507-516.